Authors say findings highlight the need for infection prevention
MONDAY, Sept. 9, 2024 (HealthDay News) — Periprosthetic joint infection (PJI) within one year of total hip arthroplasty is associated with a more than fivefold increased risk for mortality within 10 years, according to a study published online Sept. 4 in the Journal of Bone & Joint Surgery.
Raman Mundi, M.D., from the Sunnybrook Research Institute at the University of Toronto, and colleagues assessed the long-term mortality risk associated with PJI following total hip arthroplasty. The analysis included 175,432 patients (54.7 percent women) who underwent first primary elective total hip arthroplasty for arthritis between April 1, 2002, and March 31, 2021.
The researchers found that 0.49 percent of patients underwent surgery for a PJI of the replaced joint within one year after the index procedure. Patients with a PJI within the first year had a significantly higher 10-year mortality rate than matched peers (11.4 percent versus 2.2 percent without PJI; hazard ratio, 5.49).
“The results of this study build on previous evidence to help delineate the causal association between PJI and increased mortality risk,” the authors write. “These findings should help to bolster efforts related to the prevention, diagnosis, and treatment of PJIs, which may be considered among the most important priorities for future musculoskeletal research.”
Abstract/Full Text (subscription or payment may be required)
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Early Complications Common in Older Kidney Transplant Recipients
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
Frequent Cannabis Use Linked to Epilepsy Severity
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes